Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,977 public trials 2,028 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Recruiting

Munich ME/CFS Cohort Study

NCT06005246

Conditions: COVID-19, Chronic Disease, Coronaviridae Infections, +35 more
Locations: MRI Chronic Fatigue Center for Young People (MCFC), Children's hospital, Technical University of Munich (TUM) and Munic Municipal Hospital (MüK) Munich, Bavaria, Germany

View Trial Details

Recruiting

Prospective Cohort of Single-dose Radiotherapy for Painful Bone Lesions in Multiple Myeloma

NCT05996367

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: University of Sao Paulo São Paulo, Brazil

View Trial Details

Recruiting

Integrative Medicine in Lymphoma Survivors

NCT05982223

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: Bnai Zion Medical Center Haifa, Israel

View Trial Details

Recruiting

Myeloma Novel Drug Discovery Ver 1.2

NCT05968417

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: The Royal Marsden NHS Foundation Trust Sutton, United Kingdom

View Trial Details

Recruiting

The China M-protein Screening Project in First-degree Relatives of Myeloma Patient - The CHAPERONE Study

NCT05965115

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Zhongshan Hospital，Fudan University Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Helical Tomotherapy in Multiple Myeloma

NCT05970198

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Zhongnan Hospital of Wuhan University Wuhan, Hubei, China

View Trial Details

Recruiting

Obinutuzumab in Combination With Lenalidomide in Relapsed or Refractory Marginal Zone Lymphoma

NCT05846750

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Institute of Hematology & Blood Diseases Hospital Tianjin, Tian, China

View Trial Details

Recruiting

CD70 Targeted CAR-T Cells in CD70 Positive Relapsed/Refractory Lymphoma

NCT05948033

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: China Beijing, Biotherapeutic Department of Chinsese PLA Gereral Hospital, China

View Trial Details

Recruiting

A Real-world Study of Obinutuzumab-based Therapy for Previously Untreated FL

NCT05899621

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Obinutuzumab in Combination With Lenalidomide in Relapsed or Refractory Follicular Lymphoma in Real World Study

NCT05846763

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Institute of Hematology and Blood Diseases Hospital ,Chinese Academy of Medical Sciences Tianjin, China

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions